Fluvoxamine Maleate Patent Expiration
Fluvoxamine Maleate is Used for treating obsessive-compulsive disorder with an SSRI. It was first introduced by Solvay Pharmaceuticals
Fluvoxamine Maleate Patents
Given below is the list of patents protecting Fluvoxamine Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Luvox Cr | US7465462 | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
May 10, 2020
(Expired) | Jazz Pharms |
Fluvoxamine Maleate's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Fluvoxamine Maleate:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial | Cardresearch | NA |
COMPLETED
(Apr 1, 2026)
| PHASE3 |